Cambiar Investors’s NuVasive, Inc. NUVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-41,348
Closed -$1.72M 159
2023
Q2
$1.72M Sell
41,348
-5,531
-12% -$227K 0.07% 131
2023
Q1
$1.94M Buy
46,879
+10
+0% +$428 0.08% 128
2022
Q4
$1.93M Buy
46,869
+12,767
+37% +$517K 0.09% 127
2022
Q3
$1.49M Sell
34,102
-382
-1% -$18.5K 0.08% 118
2022
Q2
$1.7M Sell
34,484
-7,313
-17% -$392K 0.08% 108
2022
Q1
$2.37M Sell
41,797
-1,881
-4% -$99.9K 0.09% 120
2021
Q4
$2.29M Sell
43,678
-3,650
-8% -$198K 0.08% 129
2021
Q3
$2.83M Sell
47,328
-717
-1% -$44.2K 0.1% 113
2021
Q2
$3.26M Buy
48,045
+848
+2% +$57.9K 0.1% 98
2021
Q1
$3.09M Buy
+47,197
New +$2.83M 0.11% 101

Other funds holding NUVA

Cambiar Investors's NUVA Position: Q3 2023 in Review

Cambiar Investors sold out of NuVasive, Inc. (NUVA) in Q3 2023, closing a stake of 41,348 shares — an estimated $1.72M sold.

Cambiar Investors first reported a position in NUVA in Q1 2021 and held it in 10 quarters. The position peaked at $3.26M in Q2 2021. 2 funds tracked by Wall St. Rank hold NUVA as of Q3 2023.

  • Cambiar Investors reported no remaining NuVasive, Inc. position as of Q3 2023 after selling out during the quarter.
  • Cambiar Investors sold 41,348 NuVasive, Inc. shares in Q3 2023, an estimated $1.72M.
  • Cambiar Investors first reported a position in NuVasive, Inc. in Q1 2021 and held it in 10 quarters.
  • Cambiar Investors's NuVasive, Inc. position peaked at $3.26M in Q2 2021.
  • 2 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q3 2023.

Based on Cambiar Investors's 13F filing for Q3 2023, filed 30 Oct 2023.